- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Article
Newer May Not Always Be Better
About 15 years ago, while riding on a shuttle bus at the annual American Academy of Dermatology meeting, I overheard two elderly dermatologists discussing the state of dermatology, as they perceived it. One gentleman commented that he had not seen a single advance to rival the advent of tetracycline for acne, and that most of the new treatments did not work very well. At the time, I remember thinking that these practitioners were out of touch with all of the hot new therapies for skin disorders. Since that time, as I have been bombarded by myriad new and supposedly revolutionary "advances," I, too, am beginning to question whether we should equate the concept of "newness"
Related Videos
Optimizing Laser Therapy for Vascular Anomalies: Why Early Multidisciplinary Care Matters
Insights From the ADORING 3 Study and Tapinarof’s Treatment-Free Periods in AD
Tattoo Ink Risks, MultiFrax Laser, and the Impact of GLP-1 Medications on Skin Health
How Mindy Haws, MD, Empowers Women in Aesthetic Medicine
LIMITLESS: A Collaborative Effort Between Allergan, The Aesthetic Society, and The American Society of Plastic Surgeons
How the LIMITLESS Initiative Supports Female Leaders in Dermatology
Aesthetic Treatments: More Than Just Enhancements, A Path to Empowerment
Four Key Factors When Buying Dermatology Devices
Chilukuri’s Approach to Safer Aesthetic Treatments
The Future of Pediatric Care at MOPD
Related Content
